An 11-year-old boy had hypoparathyroidism and Addison’s disease. During treatment with calcitriol, calcium, hydrocortisone and 9-α-fluorocortisol, he developed an apparent mineralocorticoid excess and growth retardation. Pseudohyperaldosteronism even persisted after treatment with 9-α-fluorocortisol was stopped and hydrocortisone was reduced to 6 mg/m2. The boy reported an excessive daily intake of 300–400 g liquorice corresponding to 600–800 mg glycyrrhizic acid because of salt craving. After complete withdrawal of liquorice all symptoms of hypermineralocorticoidism diminished and growth velocity increased. We hypothesise that inhibition of 11β-hydroxysteroid dehydrogenase by liquorice caused hypermineralocorticoidism and growth retardation via increased levels of free cortisol in this patient. We conclude that self-medication with liquorice in children with Addison’s disease should be considered during treatment.

Keywords:
Liquorice, Addison’s disease, Hypoparathyroidism, Hypermineralocorticoidism, Growth retardation
1.
Davis EA, Morris DJ: Medicinal use of licorice through the millennia: The good and plenty of it. Mol Cell Endocrinol 1991;78:1–6.
2.
Cotterill JA, Cunliffe WJ: Self-medication with liquorice in a patient with Addison’s disease. Lancet 1973;ii:294–295.
3.
Edwards CR: Renal 11-beta-hydroxysteroid dehydrogenase: A mechanism ensuring mineralocorticoid specifity. Horm Res 1990;34:114–117.
4.
Varese RV, Biglieri EG, Shackleton CHL, Irony I, Gomez-Fontes R: Licorice-induced hypermineralocorticoidism. N Engl J Med 1991;325:223–1227.
5.
Stewart PM, Wallace AM, Valentino R, Burt D, Shackleton CHL, Edwards CRW: Mineralocorticoid activity of liquorice: 11-β-Hydroxysteroid dehydrogenase deficiency comes of age. Lancet 1987;ii:821–824.
6.
Epstein MT, Espiner EA, Donald RA, Hughes H, Cowles RJ: Licorice raises urinary cortisol in man. J Clin Endocrinol Metab 1978;47:397–400.
7.
Borst JGG, de Vries LA, ten Holt SP, Molhuysen JA: Synergistic action of liquorice and cortisone in Addison’s and Simmond’s disease. Lancet 1953;ii:657–668.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.